Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Koji Takeda et al.|Journal of Clinical Oncology|2019Cited by 168
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Yuichi Takiguchi et al.|JAMA Oncology|2020Cited by 119